FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Guide on Postmarketing Requirements/Commitments

Federal Register notice: FDA makes available a draft guidance entitled Annual Status Report Information and Other Submissions for Postmarketing Requir...

Human Drugs

Lilly Retains Outside Consultant to Help After Inspections

Eli Lilly says it has retained an outside consultant to conduct a comprehensive independent review of systems at its Branchburg, NJ site, following tw...

Human Drugs

Fast Track Designation for TG Therapeutics Cancer Drug

FDA grants fast track designation for TG Therapeutics ublituximab and umbralisib to treat chronic lymphocytic leukemia.

Human Drugs

FDA Prevagen Concerns Aired

A Wired investigation details how Quincy Bioscience has made millions from Prevagen sales despite many FDA questions and consumer complaints.

Medical Devices

Tyber Medical Foot/Ankle Plating Systems Cleared

FDA clears a Tyber Medical 501(k) for its new line of foot and ankle plating systems.

Medical Devices

FDA Wants More Info on Helius Technologies PoNS

FDA asks Helius Medical Technologies for more information to support its request for de novo clearance of its portable neuromodulation stimulator.

Human Drugs

Feds Settle with Purdue Pharma and Sackler Family

The Justice Department announces a global settlement with Purdue Pharma and the Sackler family worth more than $8.3 billion.

Biologics

AstraZeneca U.S. Covid Vaccine Trial Expected to Resume

Covid-19 vaccine watchers expect FDA to soon remove a clinical hold on AstraZenecas Covid-19 vaccine trial after it completed its review of a serious ...

Human Drugs

CGMP Violations at RLC Labs

FDA warns RLC Labs about CGMP and other violations in its production of unapproved biologic products.

Biologics

Merck Positive Data on Pneumococcal Conjugate Vaccine

Merck reports positive findings from two Phase 3 studies evaluating the safety, tolerability and immunogenicity of V114, the companys investigational ...